Short answer
Labcorp (LH) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $3.7B (up 5.8% year over year) with net income of $299M.
Q2 2026 key financials · XBRL
- Revenue
- $3.7B
- +5.8% YoY · +5.5% QoQ
- Net income
- $299M
- +25.6% YoY · +7.5% QoQ
- Operating margin
- 12.1%
- Gross margin
- 29.8%
- EPS (diluted)
- $3.64
- +28.2% YoY · +8.7% QoQ
Source: XBRL data from the Labcorp (LH) Q2 2026 10-Q on SEC EDGAR. USD.
Labcorp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $3,731.1, up 5.8% YoY from $3,527.3
- BLS strongest segment: revenue $836.2, up 6.5%; Dx revenue $2,900.7, up 5.5%
- Operating income $451.6, up 14.5%; cost margin 29.8% vs 29.7% YoY
- BLS operating margin 17.0% vs 15.7%; Dx margin 18.0% vs 17.6%
- Headwinds: OBBBA could reduce insurance coverage and diagnostics utilization; no material impact currently expected
Risk Factors
- No risk-factors section provided; supplied text covers share repurchases, insider trading arrangements, and exhibits
- Share repurchase authorization expanded to $1,378.6 million on July 8, 2026
- Quarterly repurchases totaled 1.3 million shares at average $260.30 per share
- Rule 10b5-1 arrangements covered planned sales of 1,178 and 3,000 shares through December 31, 2027 and August 10, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Labcorp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.